Browsing by Author "Creadon-Swindell, Geralyn"

Now showing 1 - 1 of 1
  • Thumbnail Image
    Item
    Pathogenic variants in MRPL44 causes infantile cardiomyopathy due to a mitochondrial translation defect
    (Elsevier, 2021) Friederich, Marisa W.; Geddes, Gabrielle C.; Wortmann, Saskia B.; Punnoose, Ann; Wartchow, Eric; Knight, Kaz M.; Prokisch, Holger; Creadon-Swindell, Geralyn; Mayr, Johannes A.; Van Hove, Johan L. K.; Medical and Molecular Genetics, School of Medicine
    Cardiac dysfunction is a common phenotypic manifestation of primary mitochondrial disease with multiple nuclear and mitochondrial DNA pathogenic variants as a cause, including disorders of mitochondrial translation. To date, five patients have been described with pathogenic variants in MRPL44, encoding the ml44 protein which is part of the large subunit of the mitochondrial ribosome (mitoribosome). Three presented as infants with hypertrophic cardiomyopathy, mild lactic acidosis, and easy fatigue and muscle weakness, whereas two presented in adolescence with myopathy and neurological symptoms. We describe two infants who presented with cardiomyopathy from the neonatal period, failure to thrive, hypoglycemia and in one infant lactic acidosis. A decompensation of the cardiac function in the first year resulted in demise. Exome sequencing identified compound heterozygous variants in the MRPL44 gene including the known pathogenic variant c.467T>G and two novel pathogenic variants. We document a combined respiratory chain enzyme deficiency with emphasis on complex I and IV, affecting heart muscle tissue more than skeletal muscle or fibroblasts. We show this to be caused by reduced mitochondrial DNA encoded protein synthesis affecting all subunits, and resulting in dysfunction of complex I and IV assembly. The degree of oxidative phosphorylation dysfunction correlated with the impairment of mitochondrial protein synthesis due to different pathogenic variants. These functional studies allow for improved understanding of the pathogenesis of MRPL44-associated mitochondrial disorder.